Pura Vida Investments, LLC Kura Oncology, Inc. Transaction History

Pura Vida Investments, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$11.78 - $16.98 $1.06 Million - $1.52 Million	-89,612 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$12.22 - $19.57 $77,548 - $124,191	6,346 Added 7.62%	89,612 $1.26 Million
Q3 2021 Nov 15, 2021	SELL	$15.42 - $21.72 $255,910 - $360,465	-16,596 Reduced 16.62%	83,266 $1.56 Million
Q2 2021 Aug 16, 2021	SELL	$20.85 - $29.88 $508,281 - $728,414	-24,378 Reduced 19.62%	99,862 $2.08 Million
Q1 2021 May 12, 2021	BUY	$24.75 - $39.14 $1.2 Million - $1.9 Million	48,440 Added 63.91%	124,240 $3.51 Million
Q4 2020 Feb 16, 2021	SELL	$29.0 - $41.62 $761,714 - $1.09 Million	-26,266 Reduced 25.73%	75,800 $2.48 Million
Q3 2020 Nov 16, 2020	BUY	$16.3 - $30.64 $1.66 Million - $3.13 Million	102,066 New	102,066 $3.13 Million
Q1 2018 May 14, 2018	SELL	$14.5 - $23.4 $725,000 - $1.17 Million	-50,000 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$13.5 - $16.65 $675,000 - $832,499	50,000	50,000 $0

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $1.06B
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.